Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
2.400
+0.020 (0.84%)
Dec 26, 2025, 10:02 AM EST - Market open
Health Catalyst Stock Forecast
Stock Price Forecast
The 10 analysts that cover Health Catalyst stock have a consensus rating of "Hold" and an average price target of $4.30, which forecasts a 79.17% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $6.00.
Price Target: $4.30 (+79.17%)
Analyst Consensus: Hold
* Price targets were last updated on Nov 11, 2025.
Analyst Ratings
The average analyst rating for Health Catalyst stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 5 | 3 | 2 | 2 | 2 | 2 |
| Hold | 4 | 7 | 8 | 8 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $3.5 → $3.25 | Hold | Maintains | $3.5 → $3.25 | +35.42% | Nov 11, 2025 |
| Stifel | Stifel | Hold Maintains $4.5 → $3.75 | Hold | Maintains | $4.5 → $3.75 | +56.25% | Nov 11, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +108.33% | Nov 11, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +25.00% | Oct 8, 2025 |
| Keybanc | Keybanc | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +66.67% | Oct 8, 2025 |
Financial Forecast
Revenue This Year
316.49M
from 306.58M
Increased by 3.23%
Revenue Next Year
307.86M
from 316.49M
Decreased by -2.73%
EPS This Year
0.21
from -1.15
EPS Next Year
0.37
from 0.21
Increased by 76.04%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 327.1M | 322.9M | ||
| Avg | 316.5M | 307.9M | ||
| Low | 303.7M | 292.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 6.7% | 2.0% | ||
| Avg | 3.2% | -2.7% | ||
| Low | -0.9% | -7.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.26 | 0.65 | ||
| Avg | 0.21 | 0.37 | ||
| Low | 0.18 | 0.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 211.3% | ||
| Avg | - | 76.0% | ||
| Low | - | -1.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.